Clik here to view.
Forecasting the future of biologics
Précis: Peter Mansell reports on how to balance complexity and predictability when forecasting for biologics The growing presence of biologics in R&D pipelines and on the pharmaceutical market has...
View ArticleClik here to view.
Biosimilars: The new iPad or Sony Betamax?
Précis: Globally, while the total sales of biological agents continue to grow, branded biologic manufacturers are facing increasing competition from biosimilars, and while some biosimilars are having...
View ArticleClik here to view.
$13.6 Billion Buyout of Life Tech by Thermo Fisher Creates Personalized...
Précis: In one of the America’s biggest corporate takeovers this year, science service provider Thermo Fisher Scientific has brought out the scientific and laboratory equipment maker Life Technologies...
View ArticleClik here to view.
Florida Joins Growing Number of States Passing Biosimilar Substitution Bills
Précis: Last week, the state of Florida passed legislation allowing for the substitution of biologics with biosimilars alternatives, joining a growing list of states in America to do so. The...
View ArticleClik here to view.
Bio Boy! Developing Markets to See Surge in Biosimilar Drug Growth
Précis: The global biosimilar drug market for 2013 will see a 20% growth on last year’s figures to a whopping $2.44 billion, and a new survey indicates that this trend will continue to flourish for...
View ArticleClik here to view.
New Research Holds Potential For Production Of Purer And Cheaper DNA Molecule...
Précis: A novel way to mass produce specific DNA molecules is believed to hold the key for many of the challenges that come with current production methods. This ultimately means that high quality DNA...
View ArticleClik here to view.
EMA Releases Final Guidance on Biosimilars, Seeks Comment
Précis: The EMA has released the last of a series of three proposed guidelines on biosimilar medicines for public six-month consultation. The latest document sets out the EMA’s current position...
View ArticleClik here to view.
Barriers to Biologic Treatment - Is Injecting Such a Pain?
Précis: Mary Assimakopoulos examines a common yet often unaddressed patient concern – the very human fear of needles! Insights from our market research into autoimmune diseases clearly demonstrate...
View Article
